{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"carnitine-palmitoyl-transferase-ii-deficiency-myopathic-form","columns":[{"gene":"","key":"population-4cf4159119b71da3a77f","label":"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced","mondoId":"MONDO:0009704","onsetQualifier":null,"originColumnKey":"MONDO:0009704/OMIM:255110","originalViews":[{"key":"MONDO:0009704/OMIM:255110","label":"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced","scopeLabel":"OMIM:255110","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["047dac05c9c37a9cbf980bbb72ce3c06187cd00855924154ad48e6871ca5a703","117bcb722686357c5874869448498e601f174b2decd4b71762e4751374a74f77","18bc1095c0169424592fed1b1d8deecee89e4994853f6bdfe968c92b61ba50aa","c21774c0525e9971ecee6a1b0eb9904e8deb08eda0dba5bb92c141d1788043f8","c904f49b16ed3c54dc4e443f040e0d16979290db5de3fd24f48c55465dd56aef","d2f1d24e70fc596f66f27c804df00ac57b88c32ac495c4e9cbab74dcd139dbf8","db455cb876dde97ef98561f2ed8473fa04e513db9d2f1758f2d7c596f039206a"],"recordQualifiers":{},"scopeLabel":"OMIM:255110","sourceIds":["OMIM:255110"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-52c33613917cecd0ad57","label":"Carnitine palmitoyl transferase II deficiency, myopathic form","mondoId":"MONDO:0009704","onsetQualifier":null,"originColumnKey":"MONDO:0009704/ORPHA:228302","originalViews":[{"key":"MONDO:0009704/ORPHA:228302","label":"Carnitine palmitoyl transferase II deficiency, myopathic form","scopeLabel":"ORPHA:228302","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0fa9e58508c7d81e802718532d4341c0b810822db4c398abab940f9d0732ef10","173536e685ded4267486ef3fc03e49242aab6e637637c24d8b3e6c221569c065","17fcb45e4d219183be8f57bd93a9f83ece18d8d1564c35f646e067f68947e465","18af7129acd592ce50c9c061a729935f147fb5bea491e7c25e9e052114f680b1","1a60b286e1ce4a70136b3a2ecc4cfe0ed723926e3cd69f36fead6d68919429d6","200367d6151dd1f8905948c072f32396d97e15c5f2203c17f5f7b3075672ac43","533cf42c3f3d9070cc98fa07d890a1599e1316d82233e6eafc76cde5cdfc350f","649d23016849244c850ec407874be0cbcb5023b8be155be4e2e856d641f567cd","6951093132352fb0dbe56eadbbf52f96e3860777f564a4440567b18cc66baf44","6cd56d920a79e06961a8f300e73a2ef264b3071063851c7c71e988c10642af46","7857f95f2f807c11c440229a5bff6fadeac40df4300c5c887befd4ebb07f6777","82a0b284d25929b5d9a61a4fffed88b0356071ae44f0b73fe9f516ec678561e5","8eaff877c75cab685e563e5d227ac5efed3e763cc53302e5ad9b41c2237442ca","8f32ca3064e7fb378f56a9764ea3ff981e14c42fe572a6f692a4ac2b2f79e3fb","982460a2c696334ac1da36a4454c129b4700e80ef606ef541aa37a585316d39d","a3ede41651dd7f4d3f551deb6308f541b23487d8050945d8ea105cca0ad812e0","a6069a8c45090cab059e6d12d44a885942532844c49da023d5eee9a3bb649802","a81b4c1e6d224ca86162ccc1122ccc6a813a905dc6d06b925123bbf0694e24f1","e688911a512c0904929080752c032d780a504b86a357318ea940ae05e3ec03f0","f03f282210e1ff0bcd35e6f6244d0dc665bb18ebd25c8b632e5eeee1e8667e89","fe48f38de530e610a5e1196785458a0de62722f9ad7a97684a4b313077ddda80"],"recordQualifiers":{},"scopeLabel":"ORPHA:228302","sourceIds":["ORPHA:228302"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-4cf4159119b71da3a77f","population-52c33613917cecd0ad57"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003449","HP:0045045","HP:0003236","HP:0003455","HP:0003546","HP:0003710","HP:0003738"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":5,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":28,"sourceGroups":{"omim":2,"orphanet":21,"published":5}},"features":[{"hpoId":"HP:0003449","label":"Cold-induced muscle cramps","primary":true},{"hpoId":"HP:0045045","label":"Elevated circulating acylcarnitine concentration","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":true},{"hpoId":"HP:0003455","label":"Elevated circulating long chain fatty acid concentration","primary":true},{"hpoId":"HP:0003546","label":"Exercise intolerance","primary":true},{"hpoId":"HP:0003710","label":"Exercise-induced muscle cramps","primary":true},{"hpoId":"HP:0003738","label":"Exercise-induced myalgia","primary":true},{"hpoId":"HP:0009058","label":"Increased muscle lipid content","primary":false},{"hpoId":"HP:0011964","label":"Intermittent painful muscle spasms","primary":false},{"hpoId":"HP:0100295","label":"Muscle fiber atrophy","primary":false},{"hpoId":"HP:0003394","label":"Muscle spasm","primary":false},{"hpoId":"HP:0003552","label":"Muscle stiffness","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0003326","label":"Myalgia","primary":false},{"hpoId":"HP:0002913","label":"Myoglobinuria","primary":false},{"hpoId":"HP:0040320","label":"Red-brown urine","primary":false},{"hpoId":"HP:0012380","label":"Reduced tissue carnitine O-palmitoyltransferase 2 activity","primary":false},{"hpoId":"HP:0000083","label":"Renal insufficiency","primary":false},{"hpoId":"HP:0008682","label":"Renal tubular epithelial necrosis","primary":false},{"hpoId":"HP:0003201","label":"Rhabdomyolysis","primary":false},{"hpoId":"HP:0003774","label":"Stage 5 chronic kidney disease","primary":false},{"hpoId":"HP:0001970","label":"Tubulointerstitial nephritis","primary":false}],"ledeHtml":"The myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited metabolic disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the most common and the least severe form of CPT II deficiency.","mondoId":"MONDO:0009704","node":{"canonicalSlug":"carnitine-palmitoyl-transferase-ii-deficiency-myopathic-form","comparisons":[{"documentSha256":"a8c7f1c11092c8bde917a86ac0edbd394cd224379115b5654d2eef0d1ffb442e","key":"legacy-carnitine-palmitoyltransferase-ii-deficiency","kind":"legacy","label":"carnitine palmitoyltransferase II deficiency","memberIds":["MONDO:0009704","MONDO:0010914","MONDO:0012136","MONDO:0015515"],"mondoId":"MONDO:0015515","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/carnitine-palmitoyltransferase-ii-deficiency.a8c7f1c11092c8bde917a86ac0edbd394cd224379115b5654d2eef0d1ffb442e.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"carnitine palmitoyl transferase II deficiency, myopathic form","paragraphs":["The myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited metabolic disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the most common and the least severe form of CPT II deficiency."],"scope":"exact","source":"MONDO","upstream":"Orphanet:228302","url":"https://monarchinitiative.org/MONDO:0009704"},"ownColumnKeys":["population-4cf4159119b71da3a77f","population-52c33613917cecd0ad57"],"publication":"published","relationships":[{"kind":"parent","label":"carnitine palmitoyltransferase II deficiency","mondoId":"MONDO:0015515","slug":"carnitine-palmitoyltransferase-ii-deficiency"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/17149"}],"translation":"published"},"records":[{"frequencyKind":"count","key":"047dac05c9c37a9cbf980bbb72ce3c06187cd00855924154ad48e6871ca5a703","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:255110","disease_name":"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced","evidence":"PCS","frequency_raw":"17/28","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"PMID:15642848","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"0fa9e58508c7d81e802718532d4341c0b810822db4c398abab940f9d0732ef10","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011964","is_excluded":false,"label":"Intermittent painful muscle spasms","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"117bcb722686357c5874869448498e601f174b2decd4b71762e4751374a74f77","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:255110","disease_name":"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced","evidence":"PCS","frequency_raw":"27/28","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"PMID:15642848","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"173536e685ded4267486ef3fc03e49242aab6e637637c24d8b3e6c221569c065","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0045045","is_excluded":false,"label":"Elevated circulating acylcarnitine concentration","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"17fcb45e4d219183be8f57bd93a9f83ece18d8d1564c35f646e067f68947e465","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001970","is_excluded":false,"label":"Tubulointerstitial nephritis","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"18af7129acd592ce50c9c061a729935f147fb5bea491e7c25e9e052114f680b1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003455","is_excluded":false,"label":"Elevated circulating long chain fatty acid concentration","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"18bc1095c0169424592fed1b1d8deecee89e4994853f6bdfe968c92b61ba50aa","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:255110","disease_name":"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003552","is_excluded":false,"label":"Muscle stiffness","onset_id":null,"reference":"OMIM:255110","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"1a60b286e1ce4a70136b3a2ecc4cfe0ed723926e3cd69f36fead6d68919429d6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003449","is_excluded":false,"label":"Cold-induced muscle cramps","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"200367d6151dd1f8905948c072f32396d97e15c5f2203c17f5f7b3075672ac43","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008682","is_excluded":false,"label":"Renal tubular epithelial necrosis","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"533cf42c3f3d9070cc98fa07d890a1599e1316d82233e6eafc76cde5cdfc350f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"649d23016849244c850ec407874be0cbcb5023b8be155be4e2e856d641f567cd","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012380","is_excluded":false,"label":"Reduced tissue carnitine O-palmitoyltransferase 2 activity","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6951093132352fb0dbe56eadbbf52f96e3860777f564a4440567b18cc66baf44","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6cd56d920a79e06961a8f300e73a2ef264b3071063851c7c71e988c10642af46","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003738","is_excluded":false,"label":"Exercise-induced myalgia","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7857f95f2f807c11c440229a5bff6fadeac40df4300c5c887befd4ebb07f6777","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100295","is_excluded":false,"label":"Muscle fiber atrophy","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"82a0b284d25929b5d9a61a4fffed88b0356071ae44f0b73fe9f516ec678561e5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0009058","is_excluded":false,"label":"Increased muscle lipid content","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8eaff877c75cab685e563e5d227ac5efed3e763cc53302e5ad9b41c2237442ca","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003774","is_excluded":false,"label":"Stage 5 chronic kidney disease","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8f32ca3064e7fb378f56a9764ea3ff981e14c42fe572a6f692a4ac2b2f79e3fb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003201","is_excluded":false,"label":"Rhabdomyolysis","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"982460a2c696334ac1da36a4454c129b4700e80ef606ef541aa37a585316d39d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0040320","is_excluded":false,"label":"Red-brown urine","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a3ede41651dd7f4d3f551deb6308f541b23487d8050945d8ea105cca0ad812e0","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003394","is_excluded":false,"label":"Muscle spasm","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a6069a8c45090cab059e6d12d44a885942532844c49da023d5eee9a3bb649802","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002913","is_excluded":false,"label":"Myoglobinuria","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a81b4c1e6d224ca86162ccc1122ccc6a813a905dc6d06b925123bbf0694e24f1","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"c21774c0525e9971ecee6a1b0eb9904e8deb08eda0dba5bb92c141d1788043f8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:255110","disease_name":"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced","evidence":"PCS","frequency_raw":"22/28","hpo_id":"HP:0002913","is_excluded":false,"label":"Myoglobinuria","onset_id":null,"reference":"PMID:15642848","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c904f49b16ed3c54dc4e443f040e0d16979290db5de3fd24f48c55465dd56aef","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:255110","disease_name":"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced","evidence":"PCS","frequency_raw":"5/28","hpo_id":"HP:0003201","is_excluded":false,"label":"Rhabdomyolysis","onset_id":null,"reference":"PMID:15642848","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"d2f1d24e70fc596f66f27c804df00ac57b88c32ac495c4e9cbab74dcd139dbf8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:255110","disease_name":"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003394","is_excluded":false,"label":"Muscle spasm","onset_id":null,"reference":"OMIM:255110","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"db455cb876dde97ef98561f2ed8473fa04e513db9d2f1758f2d7c596f039206a","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:255110","disease_name":"Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced","evidence":"PCS","frequency_raw":"5/28","hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"PMID:15642848","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"e688911a512c0904929080752c032d780a504b86a357318ea940ae05e3ec03f0","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f03f282210e1ff0bcd35e6f6244d0dc665bb18ebd25c8b632e5eeee1e8667e89","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003546","is_excluded":false,"label":"Exercise intolerance","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fe48f38de530e610a5e1196785458a0de62722f9ad7a97684a4b313077ddda80","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:228302","disease_name":"Carnitine palmitoyl transferase II deficiency, myopathic form","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003710","is_excluded":false,"label":"Exercise-induced muscle cramps","onset_id":null,"reference":"ORPHA:228302","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009704\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:228302</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>The myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited metabolic disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the most common and the least severe form of CPT II deficiency.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009704\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"carnitine-palmitoyl-transferase-ii-deficiency-myopathic-form","sourceDocuments":[{"name":"MONDO: carnitine palmitoyl transferase II deficiency, myopathic form","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009704"}],"sourceNote":"","synonyms":["Carnitine palmitoyl transferase deficiency type 2, adult-onset form","Carnitine palmitoyl transferase deficiency type 2, myopathic form","Carnitine palmitoyl transferase II deficiency, adult-onset form","carnitine palmitoyl transferase II deficiency, myopathic form","CPT II deficiency, myopathic, stress-induced","CPT2, adult-onset form","CPT2, myopathic form","CPTII, adult-onset form","CPTII, myopathic form"],"takeawayHtml":"","title":"carnitine palmitoyl transferase II deficiency, myopathic form"},"schemaVersion":1}
